Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Jallouk

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Bioconjugate Chemistry|June 18, 2015
Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon NanoparticlesAndrew P Jallouk, Rohun U Palekar, Jon N Marsh, et al.
Bone Marrow Transplantation|September 10, 2024
Progressive multifocal leukoencephalopathy after CAR-T cell therapyMichael Montoya, Hannah J Harmsen, Brittney Baer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 11, 2015
Quantifying progression and regression of thrombotic risk in experimental atherosclerosisRohun U Palekar, Andrew P Jallouk, Matthew J Goette, et al.
Transplantation and Cellular Therapy|May 14, 2026
Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyOlalekan O Oluwole, Leslie Crofford, Andrew P Jallouk, et al.
Bone Marrow Transplantation|April 2, 2026
Outcomes of hematopoietic stem cell transplantation in patients aged 70 years and olderRachel B Gorham, Salyka Sengsayadeth, Christina A Snider, et al.
Haematologica|November 17, 2022
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic responseAndrew P Jallouk, Sushanth Gouni, Jason Westin, et al.
Haematologica|November 30, 2023
Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapyAndrew P Jallouk, Naishu Kui, Ryan Sun, et al.
Blood Advances|June 9, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamabAllison M Bock, Lei Feng, Ayushi Chauhan, et al.
Leukemia|September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapyPaolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bioconjugate Chemistry|June 18, 2015
Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon NanoparticlesAndrew P Jallouk, Rohun U Palekar, Jon N Marsh, et al.
Bone Marrow Transplantation|September 10, 2024
Progressive multifocal leukoencephalopathy after CAR-T cell therapyMichael Montoya, Hannah J Harmsen, Brittney Baer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 11, 2015
Quantifying progression and regression of thrombotic risk in experimental atherosclerosisRohun U Palekar, Andrew P Jallouk, Matthew J Goette, et al.
Transplantation and Cellular Therapy|May 14, 2026
Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyOlalekan O Oluwole, Leslie Crofford, Andrew P Jallouk, et al.
Bone Marrow Transplantation|April 2, 2026
Outcomes of hematopoietic stem cell transplantation in patients aged 70 years and olderRachel B Gorham, Salyka Sengsayadeth, Christina A Snider, et al.
Haematologica|November 17, 2022
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic responseAndrew P Jallouk, Sushanth Gouni, Jason Westin, et al.
Haematologica|November 30, 2023
Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapyAndrew P Jallouk, Naishu Kui, Ryan Sun, et al.
Blood Advances|June 9, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamabAllison M Bock, Lei Feng, Ayushi Chauhan, et al.
Leukemia|September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapyPaolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Pageof 2